Considering that HFRS patients might receive dialysis treatment or continuous renal replacement therapy (Liu et al., 2019), which would affect the results of serum parameter measurements, NEAT1-2 in monocytes could be a better biomarker than serum viral load or PLT count. The gene discussed is NEAT1; the disease is hemorrhagic fever with renal syndrome.